Kakagia Despoina D, Papanas Nikolaos, Karadimas Efthimios, Polychronidis Alexandros
Department of Surgery-Plastic Surgery, Democritus University of Thrace, Alexandoupolis, Greece.
Department of Internal Medicine, Democritus University of Thrace, Alexandoupolis, Greece.
Ann Dermatol. 2014 Feb;26(1):96-8. doi: 10.5021/ad.2014.26.1.96. Epub 2014 Feb 17.
Warfarin-induced skin necrosis is an infrequent complication occurring in individuals under warfarin treatment who have a thrombophilic history or after administration of large loading doses of warfarin particularly without simultaneous initial use of heparin. A 62-year-old lady developed skin necrosis 4 days after initiating warfarin therapy of 5 mg daily without initial co-administration of heparin. The patient had a normal clotting profile. Skin necrosis progressed to eschar formation after cessation of warfarin and heparinization stopped expanding. Warfarin was reintroduced at 2 mg daily, initially together with low molecular weight heparin. Autolytic debridement of the necrotic tissue was followed by healing of the cutaneous deficit by secondary intention. Prompt diagnosis and discontinuation of warfarin are crucial for the prognosis.
华法林诱导的皮肤坏死是一种罕见的并发症,发生在有血栓形成倾向病史的接受华法林治疗的个体中,或在给予大剂量负荷剂量的华法林后,特别是在没有同时初始使用肝素的情况下。一名62岁女性在开始每日5毫克华法林治疗且未初始联合使用肝素4天后出现皮肤坏死。患者凝血指标正常。停用华法林且肝素化停止扩展后,皮肤坏死进展为焦痂形成。华法林以每日2毫克重新开始使用,最初与低分子量肝素一起使用。坏死组织进行自溶性清创后,皮肤缺损通过二期愈合得以愈合。及时诊断和停用华法林对预后至关重要。